Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

160
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
160
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

51
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
51
Altered States of Awareness01:06

Altered States of Awareness

164
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
164
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

69
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
69
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

133
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
133
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

208
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
208

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using secondary costing data to inform priority setting: a survey of current approaches for TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Social anxiety and paranoid beliefs in adolescents.

JCPP advances·2025
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Contamination effects in cluster randomised trials of TB interventions.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

"It's Time to see What I Can Do": A Mixed-Methods Investigation into Trajectories of Resilience in Adolescents during the COVID-19 Pandemic.

Journal of child & adolescent trauma·2024
Same author

Genome Wide Conditional Mouse Knockout Resources.

Drug discovery today. Disease models·2024

Related Experiment Video

Updated: Jun 16, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.5K

Do hallucinations exist on a continuum with subclinical hallucinatory experiences? A multi-method taxometric study.

A Elahi1, C Fletcher2, G Perez Algorta3

  • 1Department of Primary Care and Mental Health, University of Liverpool, UK.

Schizophrenia Research
|May 24, 2025
PubMed
Summary

This study investigated whether hallucinations are dimensional or taxonic. Findings suggest hallucinations may be dimensional, particularly in non-clinical groups, impacting psychosis classification and treatment.

Keywords:
HallucinationsL-MODEMAMBACMAXEIGTaxometrics

More Related Videos

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

17.3K
Assessment and Communication for People with Disorders of Consciousness
07:37

Assessment and Communication for People with Disorders of Consciousness

Published on: August 1, 2017

9.0K

Related Experiment Videos

Last Updated: Jun 16, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.5K
Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

17.3K
Assessment and Communication for People with Disorders of Consciousness
07:37

Assessment and Communication for People with Disorders of Consciousness

Published on: August 1, 2017

9.0K

Area of Science:

  • Psychiatry and Mental Health
  • Latent Structure Analysis
  • Psychometric Evaluation

Background:

  • Debate exists on whether psychosis symptoms are dimensional or taxonic.
  • Understanding this has implications for psychosis classification, assessment, and treatment.
  • Previous research indicated paranoia has a dimensional structure; this study examines hallucinations.

Purpose of the Study:

  • To assess the latent structure of hallucinations using taxometric methods.
  • To determine if hallucinations exist on a continuum with healthy functioning or as a distinct category.
  • To investigate the dimensional versus taxonic nature of hallucinatory experiences.

Main Methods:

  • Employed three taxometric procedures: MAMBAC, MAXEIG, and L-MODE.
  • Utilized data from a diverse sample including clinical (n=290) and non-clinical (n=1580) participants.
  • Administered the Launay-Slade Hallucinations Scale-Revised (LSHS-R) to all participants.

Main Results:

  • Three of six taxometric analyses indicated a strong dimensional structure for hallucinations.
  • Further analyses leaned towards a dimensional interpretation, especially in the non-clinical sample.
  • One analysis yielded ambiguous results, supporting neither a dimension nor a taxon.

Conclusions:

  • Findings suggest hallucinations may possess a dimensional latent structure, similar to paranoia.
  • Results indicate potential implications for the classification and treatment of psychosis.
  • Caution is advised due to potential scale limitations; further research with diverse populations and improved assessments is recommended.